2025 Non-GAAP EPS Guidance: $3.40 to $3.50. Globus Medical Inc (NYSE:GMED) achieved record sales in 2024 with revenue reaching $2.519 billion, marking a 61% increase compared to the previous year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback